ARTICLE | Clinical News
AVI preclinical data
April 10, 2000 7:00 AM UTC
AVII said that its Neugene antisense compound against c-myc significantly decreased tumor growth in mice. Data were presented at the American Association for Cancer Research meeting in San Francisco. ...